ReviewJournal of basic and clinical physiology and pharmacology2025
Study on the molecular aspect of cardioprotective effects of selenium: a mini-review.
Review in Journal of basic and clinical physiology and pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selenium (Se) is an essential micronutrient with multiple and complex effects on human health, including potent antioxidant, anti-inflammatory, and antiviral properties. Cardiovascular disease (CVD) and its most severe complications are the leading causes of mortality and disability worldwide. Considering the fact that oxidative stress and inflammation are central to CVDs, this review focuses on different cardioprotective characteristics of Se with a special focus on molecular mechanisms. In this review, several databases, websites, and search engines, including Medline, PubMed, Scopus, ScienceDirect, and Google Scholar, were searched using MeSH keywords of Se, Se compounds, CVD, oxidative stress, inflammation, coronary artery disease, and signaling pathway. The present study thoroughly explains the molecular pathways by which Se carries out its function to decrease cardiovascular and related diseases.
Indexed as
Identifiers
40738121What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.